CRISPR Therapeutics AG Retained Earnings (Accumulated Deficit) 2015-2024 | CRSP
CRISPR Therapeutics AG retained earnings (accumulated deficit) from 2015 to 2024. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.